Romosozumab - Promising or Practice Changing?
N Engl J Med
.
2017 Oct 12;377(15):1479-1480.
doi: 10.1056/NEJMe1711298.
Epub 2017 Sep 11.
Author
Clifford J Rosen
1
Affiliation
1
From Tufts University Medical School, Boston, and the Maine Medical Center Research Institute, Scarborough.
PMID:
28892459
DOI:
10.1056/NEJMe1711298
No abstract available
Publication types
Editorial
MeSH terms
Antibodies, Monoclonal*
Humans
Osteoporosis, Postmenopausal*
Substances
Antibodies, Monoclonal
romosozumab